Arrivo BioVentures
Latest round
- Series B
Last raised
- Nov 2023
Total raised
- $92M
Investors
- 4
About Arrivo BioVentures
Founded in 2015 and headquartered in Morrisville, US, Arrivo BioVentures LLC specializes in biopharmaceutical development. The firm was co-founded by Michael Ackermann and Stephen Butts, the latter serving as CEO.Arrivo BioVentures is committed to developing innovative biopharmaceuticals addressing the root causes of challenging diseases. Their core product offerings include SP-624, targeting major depressive disorder, and RABI-767, aimed at patients at risk of severe acute pancreatitis. Both candidates utilize novel mechanisms of action, enhancing their potential effectiveness.The revenue model of Arrivo BioVentures is primarily based on partnerships and collaborations within the pharmaceutical industry. Revenue is generated through strategic alliances, which involve shared costs and profits related to drug development and market entry. The company is targeting expansions into new global markets as its products develop, aiming to enhance accessibility for patients in need.
Who invested in Arrivo BioVentures
4 investors across 2 rounds
See all investors in Arrivo BioVentures
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Arrivo BioVentures
Who invested in Arrivo BioVentures?
Arrivo BioVentures has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Arrivo BioVentures raised?
Arrivo BioVentures has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Arrivo BioVentures last raise money?
Arrivo BioVentures's most recent round on record is a Series B, in Nov 2023.
What does Arrivo BioVentures do?
Founded in 2015 and headquartered in Morrisville, US, Arrivo BioVentures LLC specializes in biopharmaceutical development.
Where is Arrivo BioVentures headquartered?
Arrivo BioVentures is headquartered in Morrisville, US.
Which VCs invest in companies like Arrivo BioVentures?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Arrivo BioVentures's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Arrivo BioVentures? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.